CNBC: Jeffrey Kraws, Crystal Research Associates (6-14-07)

Investors wiped some 6 billion euros off the market value of French pharmaceutical company Sanofi-Aventis Thursday after the FDA rejected its weight-loss drug. CNBC's Guy Johnson talks of Sanofi's woes with Andrew Fellows, Analyst at Helvea, and Jeffrey Kraws, Senior Pharmaceutical Analyst at Crystal Research Associates.

YouTube | March 28, 2008

Tags:. .market. .company. .drug. .associates. .research